RT Book, Section A1 Fahy, Bridget N. A2 Morita, Shane Y. A2 Balch, Charles M. A2 Klimberg, V. Suzanne A2 Pawlik, Timothy M. A2 Posner, Mitchell C. A2 Tanabe, Kenneth K. SR Print(0) ID 1145761778 T1 Palliation Of Incurable Gastric Cancer T2 Textbook of Complex General Surgical Oncology YR 2018 FD 2018 PB McGraw-Hill Education PP New York, NY SN 9780071793315 LK accesssurgery.mhmedical.com/content.aspx?aid=1145761778 RD 2024/10/04 AB Gastric cancer remains a leading cause of cancer death worldwide. It is estimated that 26,370 people will be diagnosed with gastric cancer in the United States in 2013.1 Unfortunately, only 25% of patients present with localized disease, while 30% present with regional disease and 34% have distant disease at the time of diagnosis.2 Therefore, only a small percentage of patients with gastric cancer present with potentially curable disease. For the remainder of patients, the options are noncurative resection or chemotherapy with or without radiotherapy. Given this low rate of curative disease, it is critical for surgeons to be knowledgeable about management options for these patients when cure is not possible.